---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-016253"
form_type: "8-K"
ticker: "AIXC"
cik: "0001460702"
company_name: "AIxCrypto Holdings, Inc."
filed_at: "2025-06-24T23:59:59+00:00"
generated_at: "2026-05-18T22:17:35.309662+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Qualigen Therapeutics appoints Robert B. Lim as Audit Committee Chair

## Summary
- Robert B. Lim appointed Chair of Audit Committee effective June 20, 2025, replacing Graydon Bensler.
- Bensler remains on the Board and as a member of the Audit Committee.
- Lim is qualified as independent under Nasdaq rules and as an audit committee financial expert.
- No material interest or arrangement exists in connection with Lim's appointment.

## SEC filing metadata
- accession: 0001641172-25-016253
- form_type: 8-K
- ticker: AIXC
- cik: 0001460702
- company_name: AIxCrypto Holdings, Inc.
- filed_at: 2025-06-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1460702/000164117225016253/0001641172-25-016253-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1460702/000164117225016253/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-016253
- JSON: https://secwatch.observer/filing/0001641172-25-016253.json
- Plain text: https://secwatch.observer/filing/0001641172-25-016253.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.